----

**FORM      10-Q**

**For      the quarterly period ended March 31, 2008**

**333-148883**

**SPECTRUMDNA,      INC.**

| **Delaware**                                | **Pending**                        |
|---------------------------------------------|------------------------------------|
| (State                or other jurisdiction | (I.R.S.                Employer    |
| of                incorporation or          | Identification                No.) |
| organization)                               |                               |

| **1700                Park Avenue, Suite 2020** |                      |
|-------------------------------------------------|---------------------------|
| **P.O.                Box 682798**              |                      |
| **Park                City, Utah**              | **84068**                 |
| (Address                of principal            | (Zip                Code) |
| executive                offices)               |                      |

**435)      658-1349**

**Not      applicable**

| Large                  accelerated filer |  o |   | Accelerated                  filer         |  o |
|------------------------------------------|---------|--------|--------------------------------------------|---------|
| Non-accelerated                  filer   |  o |   | Smaller                  reporting company |  x |

----

----

**SPECTRUMDNA,      INC.**

**TABLE      OF CONTENTS**

|                                              |                    |                                                                        | **Page** |
|---------------------------------------------------|-------------------------|-----------------------------------------------------------------------------|----------|
| **PART                I - FINANCIAL INFORMATION** |                    |
|                                              |                    |                                                                        |     |
|                                              | Item                1.  | Financial                Statements.                                        | 3        |
|                                              | Item                2.  | Management’s                Discussion and Analysis                   |     |
|                                              |                    | of                Financial Condition and Results of Operations.            | 12       |
|                                              | Item                3.  | Quantitative                and Qualitative Disclosures About Market Risk.  | 15       |
|                                              | Item                4T. | Controls                and Procedures.                                     | 15       |
|                                              |                    |                                                                        |     |
| **PART                II - OTHER INFORMATION**    |                    |
|                                              |                    |                                                                        |     |
|                                              | Item                1.  | Legal                Proceedings.                                           | 16       |
|                                              | Item                2.  | Unregistered                Sales of Equity Securities and Use of Proceeds. | 16       |
|                                              | Item                3.  | Default                upon Senior Securities.                              | 16       |
|                                              | Item                4.  | Submission                of Matters to a Vote of Security Holders.         | 16       |
|                                              | Item                5.  | Other                Information.                                           | 16       |
|                                              | Item                6.  | Exhibits.                                                                   | 16       |
|                                              |                    |                                                                        |     |
| **SIGNATURES**                                    | 17                      |

----

**PART      I - FINANCIAL INFORMATION**

**Financial      Statements**

**SPECTRUMDNA,      INC.**

**Index      to Consolidated Financial Statements**

**Period      Ended March 31, 2008**

|                                                                                |  **Page** |
|-------------------------------------------------------------------------------------|----------------|
|                                                                                |           |
| Consolidated                Balance Sheets                                          | 4              |
|                                                                                |           |
| Consolidated                Statements of Operations                                | 5              |
|                                                                                |           |
| Consolidated                Statements of Stockholders’                Equity | 6              |
|                                                                                |           |
| Consolidated                Statements of Cash Flows                                | 7              |
|                                                                                |           |
| Notes                to Financial Statements                                        | 9              |

----

**SpectrumDNA,      Inc.**

|                                                                                                                                                 |   | March                31, |       | December                31, |   |
|------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------|------------|-----------------------------|--------|
|                                                                                                                                                 |   | 2008                     |       | 2007                        |   |
|                                                                                                                                                 |   | (unaudited)              |       |                        |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| ASSETS                                                                                                                                               |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| CURRENT                ASSETS                                                                                                                        |   |                     |       |                        |   |   |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Cash                                                                                                                                                 |   | $                        | 1,517,446  |                        | $      | 1,833,552 |   |
| Accounts                receivable                                                                                                                   |   |                     | 7,500      |                        |   | - |   |
| Prepaid                expenses                                                                                                                      |   |                     | 21,730     |                        |   | 49,154 |   |
| Employee                advances                                                                                                                     |   |                     | -          |                        |   | 1,790 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Total                Current Assets                                                                                                                  |   |                     | 1,546,676  |                        |   | 1,884,496 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| PROPERTY                AND EQUIPMENT, NET                                                                                                           |   |                     | 14,251     |                        |   | 7,527 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| OTHER                ASSETS                                                                                                                          |   |                     |       |                        |   |   |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Security                deposit                                                                                                                      |   |                     | 5,000      |                        |   | 5,000 |   |
| Patents                and trademarks                                                                                                                |   |                     | 4,425      |                        |   | 4,425 |   |
| Domain                names                                                                                                                          |   |                     | 1,888      |                        |   | 1,888 |   |
| Product                development, net                                                                                                              |   |                     | 125,417    |                        |   | 147,407 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Total                Other Assets                                                                                                                    |   |                     | 136,730    |                        |   | 158,720 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| TOTAL                ASSETS                                                                                                                          |   | $                        | 1,697,657  |                        | $      | 2,050,743 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| LIABILITIES                AND STOCKHOLDERS' EQUITY                                                                                                  |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| CURRENT                LIABILITIES                                                                                                                   |   |                     |       |                        |   |   |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Accounts                payable                                                                                                                      |   | $                        | 64,327     |                        | $      | 66,981 |   |
| Accrued                expenses                                                                                                                      |   |                     | 1,031      |                        |   | 1,031 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Total                Current Liabilities                                                                                                             |   |                     | 65,358     |                        |   | 68,012 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Total                Liabilities                                                                                                                     |   |                     | 65,358     |                        |   | 68,012 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| COMMITMENTS                                                                                                                                          |   |                     | -          |                        |   | - |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| STOCKHOLDERS'                EQUITY                                                                                                                  |   |                     |       |                        |   |   |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Preferred                stock, $0.001 par value, 10,000,000 shares authorized, -0- shares                issued                and outstanding      |   |                     | -          |                        |   | - |   |
| Common                stock, $0.001 par value, 100,000,000 shares authorized, 48,626,667                shares                issued and outstanding |   |                     | 48,627     |                        |   | 48,627 |   |
| Additional                paid-in capital                                                                                                            |   |                     | 4,316,348  |                        |   | 4,068,731 |   |
| Deficit                accumulated during the development stage                                                                                      |   |                     | (2,732,676 | )                           |   | (2,134,627 | ) |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| Total                Stockholders' Equity                                                                                                            |   |                     | 1,632,299  |                        |   | 1,982,731 |   |
|                                                                                                                                                 |   |                     |       |                        |   |   |   |
| TOTAL                LIABILITIES AND STOCKHOLDERS' EQUITY                                                                                            |   | $                        | 1,697,657  |                        | $      | 2,050,743 |   |

----

**SpectrumDNA,      Inc.**

|                                                                            |   |                         |       |                         |   | Accumulated                   |   |
|---------------------------------------------------------------------------------|--------|------------------------------|------------|------------------------------|--------|-------------------------------|--------|
|                                                                            |   |                         |       |                         |   | From                Inception |   |
|                                                                            |   | For                the Three |       | For                the Three |   | on                May 15,     |   |
|                                                                            |   | Months                Ended  |       | Months                Ended  |   | 2006                through   |   |
|                                                                            |   | March                31,     |       | March                31,     |   | March                31,      |   |
|                                                                            |   | 2008                         |       | 2007                         |   | 2008                          |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
| REVENUES,                net                                                    |   | $                            | 7,500      |                         | $      | 3,151                         |   | $ | 61,452 |   |
|                                                                            |   |                         |       |                         |   |                               |   |   |   |   |
| COST                OF SALES, net                                               |   |                         | 21,689     |                         |   | 5,052                         |   |   | 65,638 |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
|  GROSS                PROFIT (LOSS)                                        |   |                         | (14,189    | )                            |   | (1,901                        | )      |   | (4,186 | ) |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
| OPERATING                EXPENSES                                               |   |                         |       |                         |   |                          |   |   |   |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
| General                and administrative                                       |   |                         | 126,962    |                         |   | 39,079                        |   |   | 619,208 |   |
| Salaries                and wages                                               |   |                         | 407,617    |                         |   | 261,402                       |   |   | 1,945,117 |   |
| Product                development expenses                                     |   |                         | 65,560     |                         |   | 4,707                         |   |   | 248,877 |   |
| Bad                debt expense                                                 |   |                         | 90         |                         |   | -                             |   |   | 5,225 |   |
| Depreciation                                                                    |   |                         | 1,491      |                         |   | 544                           |   |   | 5,641 |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
|  Total                Operating Expenses                                   |   |                         | 601,720    |                         |   | 305,732                       |   |   | 2,824,068 |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
|  OPERATING                LOSS                                             |   |                         | (615,909   | )                            |   | (307,633                      | )      |   | (2,828,254 | ) |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
| OTHER                INCOME (EXPENSES)                                          |   |                         |       |                         |   |                          |   |   |   |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
| Interest                income                                                  |   |                         | 17,860     |                         |   | 9,307                         |   |   | 82,810 |   |
| Other                income                                                     |   |                         | -          |                         |   | 12,767                        |   |   | 12,768 |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
|  Total                Other Income (Expenses)                              |   |                         | 17,860     |                         |   | 22,074                        |   |   | 95,578 |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
|  NET                LOSS BEFORE INCOME TAXES                               |   |                         | (598,049   | )                            |   |  (285,559                | )      |   | (2,732,676 | ) |
|  INCOME                TAX EXPENSE                                         |   |                         | -          |                         |   | -                             |   |   | - |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
|  NET                LOSS                                                   |   | $                            | (598,049   | )                            | $      | (285,559                      | )      | $ | (2,732,676 | ) |
|                                                                            |   |                         |       |                         |   |                               |   |   |  |   |
|  BASIC                LOSS PER SHARE                                       |   | $                            | (0.01      | )                            | $      | (0.01                         | )      |   |   |   |
|                                                                            |   |                         |       |                         |   |                          |   |   |   |   |
| WEIGHTED                  AVERAGE NUMBER OF                  SHARES OUTSTANDING |   |                         | 48,626,667 |                         |   | 45,332,500                    |   |   |   |   |

----

**SpectrumDNA,      Inc.**

|                                                                                                                          |   |                           |   |                        |   |    |   |        |       | Additional |   |    |   |
|-------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------|--------|-----------------------------|--------|---------|--------|-------------|------------|------------|--------|---------|--------|
|                                                                                                                          |   | Preferred                Stock |   | Common                Stock |   | Paid-In |   | Accumulated |       |
|                                                                                                                          |   | Shares                         |   | Amount                      |   | Shares  |   | Amount      |       | Capital    |   | Deficit |   |
|                                                                                                                          |   |                           |   |                        |   |    |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Balance,                May 15, 2006 (inception)                                                                              |   |                           | -      |                        | $      | -       |   |        | -          |       | $      | -       |   | $ | - |   | $ | - |   |
|                                                                                                                          |   |                           |   |                        |   |    |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Issuance                of founder shares at inception                                                                        |   |                           | -      |                        |   | -       |   |        | 37,200,000 |       |   | 37,200  |   |   | (37,200 | ) |   | - |   |
| Common                shares issued for cash at $0.037 per share                                                              |   |                           | -      |                        |   | -       |   |        | 5,400,000  |       |   | 5,400   |   |   | 194,600 |   |   | - |   |
| Common                shares issued for cash at $0.50 per share                                                               |   |                           | -      |                        |   | -       |   |        | 2,025,000  |       |   | 2,025   |   |   | 1,010,475 |   |   | - |   |
| Compensation                expense associated with stock options and warrants                                                |   |                           | -      |                        |   | -       |   |        | -          |       |   | -       |   |   | 103,938 |   |   | - |   |
| Net                loss for the period from inception on May 15, 2006 through December                31,                2006 |   |                           | -      |                        |   | -       |   |        | -          |       |   | -       |   |   | - |   |   | (301,652 | ) |
|                                                                                                                          |   |                           |   |                        |   |         |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Balance,                December 31, 2006                                                                                     |   |                           | -      |                        |   | -       |   |        | 44,625,000 |       |   | 44,625  |   |   | 1,271,813 |   |   | (301,652 | ) |
|                                                                                                                          |   |                           |   |                        |   |    |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Common                shares issued for cash at $0.50 per share                                                               |   |                           | -      |                        |   | -       |   |        | 3,975,000  |       |   | 3,975   |   |   | 1,983,525 |   |   | - |   |
| Common                shares issued for services at $0.50 per share                                                           |   |                           | -      |                        |   | -       |   |        | 26,667     |       |   | 27      |   |   | 13,309 |   |   | - |   |
| Compensation                expense associated with stock options and warrants                                                |   |                           | -      |                        |   | -       |   |        | -          |       |   | -       |   |   | 800,084 |   |   | - |   |
| Net                loss for the year ended December 31, 2007                                                                  |   |                           | -      |                        |   | -       |   |        | -          |       |   | -       |   |   | - |   |   | (1,832,975 | ) |
|                                                                                                                          |   |                           |   |                        |   |    |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Balance,                December 31, 2007                                                                                     |   |                           | -      |                        |   | -       |   |        | 48,626,667 |       |   | 48,627  |   |   | 4,068,731 |   |   | (2,134,627 | ) |
|                                                                                                                          |   |                           |   |                        |   |    |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Compensation                expense associated with stock options and warrants                                                |   |                           | -      |                        |   | -       |   |        | -          |       |   | -       |   |   | 247,617 |   |   | - |   |
| Net                loss for the three months ended March 31, 2008                                                             |   |                           | -      |                        |   | -       |   |        | -          |       |   | -       |   |   | - |   |   | (598,049 | ) |
|                                                                                                                          |   |                           |   |                        |   |    |   |        |       |       |   |    |   |   |   |   |   |   |   |
| Balance,                March 31, 2008 (unaudited)                                                                            |   |                           | -      |                        | $      | -       |   |        | 48,626,667 |       | $      | 48,627  |   | $ | 4,316,348 |   | $ | (2,732,676 | ) |

----

**SpectrumDNA,      Inc.**

|                                                                                  |   |                         |      |                         |   | Accumulated                   |   |
|---------------------------------------------------------------------------------------|--------|------------------------------|-----------|------------------------------|--------|-------------------------------|--------|
|                                                                                  |   |                         |      |                         |   | From                Inception |   |
|                                                                                  |   | For                the Three |      | For                the Three |   | on                May 15,     |   |
|                                                                                  |   | Months                Ended  |      | Months                Ended  |   | 2006                through   |   |
|                                                                                  |   | March                31,     |      | March                31,     |   | March                31,      |   |
|                                                                                  |   | 2008                         |      | 2007                         |   | 2008                          |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| CASH                FLOWS FROM OPERATING ACTIVITIES                                   |   |                         |      |                         |   |                          |   |   |   |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| Net                loss                                                               |   | $                            | (598,049  | )                            | $      | (285,549                      | )      | $ | (2,732,676 | ) |
| Adjustments                to reconcile net loss to net used by operating activities: |   |                         |      |                         |   |                          |   |   |   |   |
| Depreciation                and amortization                                          |   |                         | 23,481    |                         |   | 695                           |   |   | 66,436 |   |
| Stock                options and warrants                                             |   |                         |      |                         |   |                          |   |   |   |   |
| granted                for services rendered                                          |   |                         | 247,617   |                         |   | 116,315                       |   |   | 1,151,639 |   |
| Common                stock issued for services rendered                              |   |                         | -         |                         |   | -                             |   |   | 13,336 |   |
| Changes                in operating assets and liabilities                            |   |                         |      |                         |   |                          |   |   |   |   |
| (Increase)                decrease in accounts receivable                             |   |                         | (7,500    | )                            |   | (11,000                       | )      |   | (7,500 | ) |
| (Increase)                decrease in employee advances                               |   |                         | 1,790     |                         |   | -                             |   |   | - |   |
| (Increase)                decrease in prepaid expenses                                |   |                         | 27,424    |                         |   | (4,650                        | )      |   | (21,730 | ) |
| (Increase)                decrease in security deposits                               |   |                         | -         |                         |   | -                             |   |   | (5,000 | ) |
| Increase                (decrease) in accounts payable                                |   |                         |           |                         |   |                               |   |   |   |   |
| and                accrued expenses                                                   |   |                         | (2,654    | )                            |   | 65,524                        |   |   | 65,358 |   |
| Increase                (decrease) in related party payable                           |   |                         | -         |                         |   | (10,186                       | )      |   | - |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| Net                Cash Used by Operating Activities                                  |   |                         | (307,891  | )                            |   | (128,851                      | )      |   | (1,470,137 | ) |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| CASH                FLOWS FROM INVESTING ACTIVITIES                                   |   |                         |      |                         |   |                          |   |   |   |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| Cash                paid for fixed assets                                             |   |                         | (8,215    | )                            |   | (3,015                        | )      |   | (19,892 | ) |
| Cash                paid for product development                                      |   |                         | -         |                         |   | (32,824                       | )      |   | (186,212 | ) |
| Cash                paid for intangible assets                                        |   |                         | -         |                         |   | (750                          | )      |   | (6,313 | ) |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| Net                Cash Used by Investing Activities                                  |   |                         | (8,215    | )                            |   | (36,589                       | )      |   | (212,417 | ) |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| CASH                FLOWS FROM FINIANCING ACTIVITIES                                  |   |                         |      |                         |   |                          |   |   |   |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| Cash                received from issuance of common stock                            |   |                         | -         |                         |   | 707,510                       |   |   | 3,100,000 |   |
| Cash                received on exercise of warrants                                  |   |                         | -         |                         |   | -                             |   |   | 100,000 |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| Net                Cash Provided by                                                   |   |                         |      |                         |   |                          |   |   |   |   |
| Financing                Activities                                                   |   |                         | -         |                         |   | 707,510                       |   |   | 3,200,000 |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| NET                DECREASE IN CASH                                                   |   |                         | (316,106  | )                            |   | 542,070                       |   |   | 1,517,446 |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| CASH                AT BEGINNING OF PERIOD                                            |   |                         | 1,833,552 |                         |   | 1,026,809                     |   |   | - |   |
|                                                                                  |   |                         |      |                         |   |                          |   |   |   |   |
| CASH                AT END OF PERIOD                                                  |   | $                            | 1,517,446 |                         | $      | 1,568,879                     |   | $ | 1,517,446 |   |

----

**SpectrumDNA,      Inc.**

|                                                                   |   |                         |   |                         |   | Accumulated                   |   |
|------------------------------------------------------------------------|--------|------------------------------|--------|------------------------------|--------|-------------------------------|--------|
|                                                                   |   |                         |   |                         |   | From                Inception |   |
|                                                                   |   | For                the Three |   | For                the Three |   | on                May 15,     |   |
|                                                                   |   | Months                Ended  |   | Months                Ended  |   | 2006                through   |   |
|                                                                   |   | March                31,     |   | March                31,     |   | March                31,      |   |
|                                                                   |   | 2008                         |   | 2007                         |   | 2008                          |   |
|                                                                   |   |                         |   |                         |   |                          |   |   |   |   |
| SUPPLIMENTAL                      DISCLOSURES OF CASH FLOW INFORMATION |   |                         |   |                         |   |                          |   |   |   |   |
|                                                                   |   |                         |   |                         |   |                          |   |   |   |   |
| CASH                PAID FOR:                                          |   |                         |   |                         |   |                          |   |   |   |   |
|                                                                   |   |                         |   |                         |   |                          |   |   |   |   |
| Interest                                                               |   | $                            | -      |                         | $      | -                             |   | $ | - |   |
| Income                Taxes                                            |   | $                            | -      |                         | $      | -                             |   | $ | - |   |
|                                                                   |   |                         |   |                         |   |                          |   |   |   |   |
| NON-CASH                TRANSACTIONS                                   |   |                         |   |                         |   |                          |   |   |   |   |
|                                                                   |   |                         |   |                         |   |                          |   |   |   |   |
| Common                stock issued for services                        |   | $                            | -      |                         | $      | -                             |   | $ | 13,337 |   |

----

**SPECTRUMDNA,      INC.**

|                                                                                                         |   | March 31, |       | March 31, |   |
|--------------------------------------------------------------------------------------------------------------|--------|----------------|------------|----------------|--------|
|                                                                                                         |   | 2008           |       | 2007           |   |
| Basic                earnings per share:                                                                     |   |           |       |           |   |
| Loss                (numerator)                                                                              |   | $              | (598,049   | )              | $      | (285,559 | ) |
| Weighted                average number of shares outstanding – basic                (denominator) |   |           | 48,626,667 |           |   | 45,332,500 |   |
|                                                                                                         |   |           |       |           |   |   |   |
| Per                share amount                                                                              |   | $              | (0.01      | )              | $      | (0.01 | ) |

----

**SPECTRUMDNA,      INC.**

| Dividend                yields         |   | 0.0    | %                                |
|----------------------------------------|--------|--------|----------------------------------|
| Expected                volatility     |   |   | 68.5                             | % |
| Risk-free                interest rate |   |   | 4.6                              | % |
| Option                terms            |   |   | 3 – 4 years |   |

*Common      Stock Options*

|                                            |   |    |       | Weighted |   |
|-------------------------------------------------|--------|---------|------------|----------|--------|
|                                            |   | Number  |       | Average  |   |
|                                            |   | Of      |       | Exercise |   |
|                                            |   | Options |       | Price    |   |
|                                            |   |    |       |     |   |
| Outstanding,                  December 31, 2006 |   |    | 2,970,000  |     | $      | 0.04 |   |
| Granted                                         |   |    | 6,890,180  |     |   | 0.50 |   |
| Exercised                                       |   |    | -          |     |   | - |   |
| Cancelled                                       |   |    | (1,350,000 | )        |   | 0.04 |   |
| Outstanding,                  December 31, 2007 |   |    | 8,510,180  |     | $      | 0.41 |   |
| Exercisable,                  December 31, 2007 |   |    | 1,460,833  |     | $      | 0.34 |   |
| Granted                                         |   |    | -          |     |   | - |   |
| Exercised                                       |   |    | -          |     |   | - |   |
| Cancelled                                       |   |    | -          |     |   | - |   |
| Outstanding,                  March 31, 2008    |   |    | 8,510,180  |     | $      | 0.41 |   |

----

**SPECTRUMDNA,      INC.**

| Exercisable,                March 31, 2008 |   |   | 1,545,284 |   | $ | 0.34 |   |
|--------------------------------------------|--------|--------|-----------|--------|---|------|--------|

|    | Options Outstanding                                                                                                                                    |   | Options Exercisable |      |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------|-----------|
|    |                                                                                                                                                        |   |                     |      |   |   | Weighted |   |   |   |   |   |
|    |                                                                                                                                                        |   |                     |      |   |   | Average |   |   |   |   |   |
|    | Range                                                                                                                                                       |   |                     |      | Weighted |   | Remaining |   |   |   | Weighted |   |
|    | Of                                                                                                                                                          |   |                     |      | Average |   | Contractual |   |   |   | Average |   |
|    | Exercise                                                                                                                                                    |   | Number                   |      | Exercise |   | Life |   | Number                of |   | Exercise |   |
|    | Prices                                                                                                                                                      |   | Outstanding              |      | Price |   | (in                years) |   | Options |   | Price |   |
|    |                                                                                                                                                        |   |                     |      |   |   |   |   |   |   |   |   |
|  $ |                          0.037 |   |                     | 1,620,000 |   | $ | 0.037 |   |   | 8.59 |   |   | 684,225 |   | $ | 0.037 |   |
|    | 0.500                                                                                                                                                       |   |                     | 6,890,180 |   |   | 0.050 |   |   | 9.36 |   |   | 861,059 |   |   | 0.500 |   |
|    |                                                                                                                                                        |   |                     |      |   |   |   |   |   |   |   |   |   |   |   |   |   |
|    |                                                                                                                                                        |   |                     | 8,510,180 |   |   |   |   |   |   |   |   | 1,545,284 |   | $ | 0.340 |   |

----

**Management’s      Discussion and Analysis of Financial Condition and Results of      Operations**

**Projections      and Forward-Looking Statements **

**Overview**

**Plan      of Operation**

*production*
*infrastructure*

----

*building      enginets*
*production      infrastructure*
*production      infrastructure*
*production      infrastructure*

*building      enterprises*

*production      infrastructure*
*building      enginets*

**Employees**

----

**Results      of Operations**

**For      the Three Months Ended March 31, 2008 Compared to the Three Months Ended March      31, 2007**

**Liquidity      and Capital Resources**

**Capital      Commitments**

----

**Item      3.**
**Quantitative      and Qualitative Disclosures About Market Risk**

**Item      4T.**
**Controls      and Procedures**

----

**PART      II - OTHER INFORMATION**

**Legal      Proceedings.**

**Unregistered      Sales of Equity Securities and Use of Proceeds.**

**Defaults      Upon Senior Securities.**

**Submission      of Matters to a Vote of Security-Holders.**

**Other      Information.**

**Item      6.**
**Exhibits.**

| 31.1 | Certification                of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley                Act of 2002 (Rules 13a-14 and 15d-14 of the Exchange                Act)     |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.2 | Certification                of Principal Financial Officer pursuant to Section 302 of the                Sarbanes-Oxley Act of 2002 (Rules 13a-14 and 15d-14 of the Exchange                Act) |
| 32.1 | Certification                pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.                1350)                                                                            |

----

**SIGNATURES**

|                                |   | **SPECTRUMDNA,                INC.**                 |
|-------------------------------------|--------|------------------------------------------------------|
|                                |   | (Registrant)                                         |
|                                |   |                                                 |
| Dated:                June 27, 2008 | By:    | /s/                James A. Banister                 |
|                                |   | James                A. Banister,                    |
|                                |   | President                and Chief Executive Officer |
|                                |   | (Principal                Executive Officer)         |
|                                |   |                                                 |
| Dated:                June 27, 2008 | By:    | /s/                Kelly A. McCrystal                |
|                                |   | Kelly                A. McCrystal,                   |
|                                |   | Chief                Operating Officer               |
|                                |   | (Principal                Financial Officer and      |
|                                |   | Principal                Accounting Officer)         |

----